Navigation Links
AstraZeneca Accepts Secretary of Defense Award for Supporting Employees Serving in National Guard and Reserve
Date:9/17/2009

WILMINGTON, Del., Sept. 17 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) accepted the 2009 Secretary of Defense Employer Support Freedom Award on Thursday at a ceremony in Washington, D.C. This award is the highest recognition given by the U.S. government to employers for their outstanding support of employees who serve in the National Guard and Reserve.

AstraZeneca US President Rich Fante accepted the award on behalf of AstraZeneca and was joined by AstraZeneca Vice President of Human Resources, Marta Perez, and members of the company's Military Support Employee Network Group.

"I am proud of how AstraZeneca leaders and employees are supporting not only their colleagues who serve in the National Guard and Reserve, but also their families and community members," Fante, a former Army Reservist, said.

AstraZeneca was nominated for the award by an employee from New Jersey, a current U.S. Army Reserve lieutenant colonel who has served in Afghanistan and Iraq. The company employs more than 100 men and women serving in the National Guard or Reserve, and was one of 15 employers chosen for this award from among more than 3,200 total nominations.

AstraZeneca provides flexible policies and benefits designed to ease burdens on employees serving in the National Guard or Reserve, including:

  • Providing the difference between a service member's regular pay and military pay for military service up to 24 months, after which time each employee's situation is reviewed on a case-by-case basis
  • Offering continuation of health and dental insurance for periods of military service greater than 12 months. Additionally, company-provided life insurance continues for one year after the start of the military leave and can be converted to a private plan after one year
  • Fostering a Military Support Employee Network Group, which is made up of 200 members including National Guard members and Reservists, employees who are veterans, employees whose family members are either veterans or who are currently in the service, plus employees who want to show their support of troops
  • Maintaining contact with the families of Guard and Reserve employees during periods of military service

The Freedom Award was instituted in 1996 under the auspices of the National Committee for Employer Support of the Guard and Reserve (ESGR) to recognize exceptional support from the employer community.

AstraZeneca has received numerous ESGR state awards for its support for National Guard and Reserve employees, including several Patriot Awards, the Above and Beyond Award and the Pro Patria Award.

About AstraZeneca

AstraZeneca is engaged in the research, development, manufacturing and marketing of meaningful prescription medicines and in the supply of healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with global healthcare sales of $31.6 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines. In the United States, AstraZeneca is a $13.5 billion dollar healthcare business.

For more information about AstraZeneca in the US or our AZ&Me(TM) Prescription Savings programs, please visit: www.astrazeneca-us.com.


'/>"/>
SOURCE AstraZeneca
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Video: AstraZeneca Traveling Exhibit Helps Americans Understand and Manage Bipolar Depression
2. AstraZeneca and the Artery Explorer Take California Residents on Virtual Journey Through the Arteries
3. AstraZeneca Submits New Drug Applications for ZACTIMA(TM) in Second-Line Advanced Non-Small Cell Lung Cancer
4. AstraZeneca Expands Prescription Savings Program
5. AstraZeneca Partners With Primary Health Care to Help Iowa Uninsured
6. AstraZeneca and Mental Health Research Institute in Australia Announce Collaboration to Improve Early Detection of Alzheimers Disease
7. Abbott and AstraZeneca Extend Relationship to Include Co-Promotion of TRILIPIX(R) (fenofibric acid)
8. Abbott and AstraZeneca Submit New Drug Application to the FDA for CERTRIAD(TM), an Investigational Treatment for Mixed Dyslipidemia
9. AstraZeneca Studies Show Relief of Nighttime Heartburn and Reduction in GERD-Related Sleep Disturbances
10. Verus Pharmaceuticals Announces a Lawsuit Against AstraZeneca AB and Tika Lakemedel AB
11. Court Grants AstraZeneca Preliminary Injunction Against Apotex in PULMICORT RESPULES Patent Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... Dr. Robert Mondavi, one of the ... smiles. Cosmetic dentistry is a fast-growing field as more patients are discovering the many ... learn more about the options currently available to them and which ones might work ...
(Date:4/29/2016)... ... , ... Reltok Nasal Products proudly announces that Boston Medical Products, Inc., a ... throat specialty, has added the KOTLER NASAL AIRWAY™ to its diverse product line. , ... patented safety device secured by nasal surgeons onto the floor of the nasal passages, ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... growth round of funding led by Eastside Partners, with participation from existing investor ... growing customer base and accelerate its technology and product roadmap. , ...
(Date:4/29/2016)... ... April 29, 2016 , ... Regenerative Medicine Solutions ... to Work employee satisfaction survey, earning them second place for Tampa’s Best Places to ... employees. , “This is a great accomplishment for our team,” says RMS Human ...
(Date:4/29/2016)... ... April 29, 2016 , ... The infertility specialists at HRC Fertility/Orange County (HRC/OC) ... Daniel A. Potter -- are proud of the recent release of their 2014 in ... SART published the latest verified data for 375 U.S. member clinics. *Preliminary ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... -- Glycotope GmbH, a clinical-stage immuno-oncology company ... of Dr. Alfredo Zurlo as Chief Medical ... many years clinical experience and a proven track record ... was at Mologen AG where he was Chief Medical ... Zurlo held various positions at F Hoffmann La Roche ...
(Date:4/28/2016)... 2016 Research and Markets has ... Products Market 2016-2020" report to their offering. ... The global plastic surgery products market is expected ... period 2016-2020. , ,The growing adoption of laser in ... of the market. Lasers are used to treat a ...
(Date:4/28/2016)... YORK , April 28, 2016 ... online consumer insights on healthcare, announced today that it ... their report Cool Vendor in Life Sciences, 2016, ... April 15, 2016.  The report focuses on life-science- oriented ... gain insight from patients and doctors, confirm medication ingestion, ...
Breaking Medicine Technology: